搜索此博客

2019年7月6日星期六

Lithiumgamolenate, CAS 122051-95-0;506-26-3 Sole GMP Manufacturer

Lithiumgamolenate, CAS 122051-95-0;506-26-3 Sole GMP Manufacturer

Lithiumgamolenate, CAS 122051-95-0;506-26-3 stable novel crystalline or amorphous form both we have, Lithiumgamolenate, CAS 122051-95-0;506-26-3no any IP problem. Lithiumgamolenate, CAS 122051-95-0;506-26-3 DMF filling, free sample of Lithiumgamolenate, CAS 122051-95-0;506-26-3.

EOS Med Chem have already carried out Lithiumgamolenate, CAS 122051-95-0;506-26-3 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Lithiumgamolenate, CAS 122051-95-0;506-26-3 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.

Below is Lithiumgamolenate, CAS 122051-95-0;506-26-3 Intermeidates list, most from GMP plant:

Lithiumgamolenate, CAS 122051-95-0;506-26-3(free Intermediate,  13280-07-4, stock 1.3kg, assay 98.2%, White powder.
Lithiumgamolenate, CAS 122051-95-0;
506-26-3(free Intermediate,  56909-02-5, stock 4.3kg, assay 98.2%, White powder.
Lithiumgamolenate, CAS 122051-95-0;
506-26-3(free Intermediate,  209860-37-7, stock 9.4kg, assay 98.5%, White powder.
Lithiumgamolenate, CAS 122051-95-0;
506-26-3(free Intermediate,  209860-40-2, stock 6.3kg, assay 98.1%, White powder.
Lithiumgamolenate, CAS 122051-95-0;
506-26-3(free Intermediate,  628-71-7, stock 5.4kg, assay 98.9%, White powder.
Lithiumgamolenate, CAS 122051-95-0;
506-26-3(free Intermediate,  16326-31-1, stock 7.7kg, assay 98.5%, White powder.
Lithiumgamolenate, CAS 122051-95-0;
506-26-3(free Intermediate,  16326-32-2, stock 4.6kg, assay 98.2%, White powder.
Lithiumgamolenate, CAS 122051-95-0;
506-26-3(free Intermediate,  122051-95-0, stock 5.2kg, assay 98.4%, White powder.

Lithiumgamolenate, CAS 122051-95-0;506-26-3 HNMR, MASS, COA, MSDS we have.

Lithiumgamolenate, CAS 122051-95-0;506-26-3, free sample, welcome to ask:

2019 CHINA CPHI  E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.

R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com